ENTITY
Immunotech Biopharm

Immunotech Biopharm (6978 HK)

16
Analysis
Health Care • China
Immunotech Biopharm is a cellular immunotherapy biopharmaceutical company in China, focused on the research, development, and commercialization of T-cell immunotherapy for cancer treatments. Its key products include EAL (Expanded Activated Lymphocytes), CAR-T cell series, and TCR-T cell series products. The company is headquartered in Beijing, China, and was founded in 2006.
more
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
x